Abstract

BackgroundEfficacy and safety of intravenous (IV) tocilizumab (TCZ) has been established in rheumatoid arthritis (RA). Subcutaneous (SC) TCZ injection has been developed as an additional important treatment option to enhance...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call